%0 Journal Article
%T Impact of Medical Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia on Male Sexuality
%A Thierno Oumar Diallo
%A Alimou Diallo
%A Alpha Oumar Barry
%A Emmanuel Duval Arnaud Aka
%A Mamadou Dian Barry
%A Thierno Mamadou Oury Diallo
%A Daouda Kant&#233
%A Mamadou Diao Bah
%A Abdoulaye Bobo Diallo
%A Oumar Raphiou Bah
%J Open Journal of Urology
%P 7-18
%@ 2160-5629
%D 2025
%I Scientific Research Publishing
%R 10.4236/oju.2025.151002
%X <b>Introduction</b>: Benign prostatic hyperplasia (BPH) is a benign neoplasm that develops from the constituent elements of the prostate. It is a common age-related condition, with more than 50% of men over 50 years old exhibiting symptoms indicative of BPH. It is the main cause of lower urinary tract symptoms (LUTS). <b>Materials and </b><b>Methods</b><b>:</b> This was a prospective, descriptive and longitudinal study over a six-month period from December 15, 2023, to May 15, 2024. All patients admitted for BPH and who received medication treatment during this period were included in the study. <b>Results</b>: The average age of patients was 65.4 years, with the 60 to 69-year age group being the most represented (37.18%). There was no statistical link between the level of education and the occurrence of erection dysfunction ED. 66.67% of patients suffered from ED before treatment. Age was a major risk factor. 94.87% of patients were treated with Alpha-blockers due to their tolerance and effectiveness. 14.10% of patients had a history of inguinal herniorrhaphy, often due to the strain of urination and physical labor. 46.16% of patients had hypertension. No significant link was found between comorbidities and ED. 38.45% of patients consumed tobacco or alcohol. Tobacco was a significant risk factor for ED. 57.67% of patients suffered from ED after treatment, indicating an improvement compared to 66.67% before treatment. However, 24.36% did not ejaculate during sexual intercourse. <b>Conclusion</b>: Medication treatment is the first-line treatment for BPH. However, it can lead to retrograde ejaculation, negatively impacting ejaculatory function. The results showed that the treatment improves patients&#8217; sexuality (IIEF-5 score), but age and tobacco consumption increase the risk of sexual dysfunction.
%K BPH
%K IIEF-5 Score
%K Medication Treatment
%K Sexual Dysfunction
%K Ejaculation
%K Sexuality
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=140272